Cargando…
Integrating a 19F MRI Tracer Agent into the Clinical Scale Manufacturing of a T-Cell Immunotherapy
Leukocyte immunotherapies have made great progress in the treatment of cancer. Recent reports on the treatment of B-cell malignancies using Chimeric Antigen Receptor and affinity enhanced T-Cell Receptor therapies have demonstrated encouraging clinical results. As investigators begin to explore the...
Autores principales: | O'Hanlon, Charles F., Fedczyna, Tamara, Eaker, Shannon, Shingleton, William D., Helfer, Brooke M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5688349/ https://www.ncbi.nlm.nih.gov/pubmed/29230151 http://dx.doi.org/10.1155/2017/9548478 |
Ejemplares similares
-
Clinical scale labeling of T cell immunotherapy for MRI cell tracking
por: Helfer, Brooke M, et al.
Publicado: (2015) -
Clinical cell therapy imaging using a perfluorocarbon tracer and fluorine-19 MRI
por: Ahrens, Eric T, et al.
Publicado: (2014) -
Visualizing arthritic inflammation and therapeutic response by fluorine-19 magnetic resonance imaging ((19)F MRI)
por: Balducci, Anthony, et al.
Publicado: (2012) -
Update on the Use of PET/MRI Contrast Agents and Tracers in Brain Oncology: A Systematic Review
por: Smeraldo, Alessio, et al.
Publicado: (2022) -
Breast PET/MRI Hybrid Imaging and Targeted Tracers
por: Romeo, Valeria, et al.
Publicado: (2022)